# Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer

> **NCT00003851** · NA · TERMINATED · sponsor: **Columbia University** · enrollment: 90 (estimated)

## Conditions studied

- Malnutrition
- Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** proteolytic enzymes
- **DRUG:** gemcitabine hydrochloride
- **PROCEDURE:** Gonzalez regimen

## Key facts

- **NCT ID:** NCT00003851
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-03
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 90 (ESTIMATED)
- **Why stopped:** Approval lapse
- **Last updated:** 2013-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003851, "Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00003851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*